The Prescription Drug User Fee Act target action date for the NDA is scheduled for 24 July 2026.

The MarketWatch News Department was not involved in the creation of this content.-- Centanafadine is an investigational compound for the treatment of ADHD in children, adolescents ...

Add Yahoo as a preferred source to see more of our stories on Google. A new study has investigated how different medications and therapies compare with placebos in treating ADHD symptoms. Attention ...

About 33% of children who have ADHD will continue to have ADHD into adulthood. In children, ADHD treatment depends on their ...

Attention-deficit/hyperactivity disorder (ADHD) is a common but complex neurodevelopmental condition characterized by symptoms of inattention, hyperactivity, and ...

Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental condition that causes hyperactivity and impulsivity in children and adults. If left untreated ...

A larger trial of trigeminal nerve stimulation in children with ADHD produce results that differ from an earlier pilot study, raising new questions about its efficacy.

Behavior therapy should be a first step for families who have a child with ADHD, but a Stanford Medicine study found many children are receiving medication within a month of diagnosis. Credit: Getty ...

A national shortage in a common treatment for attention-deficit hyperactivity disorder was associated with changes in stimulant prescriptions filled for children over recent years, a new study ...

Long-term methylphenidate use in childhood links to higher adult BMI and slightly shorter height, underscoring the need for ...

ADHD family therapy can involve attending therapy together with your child or separate parent sessions, depending on the age and needs of your child. This is because younger children may not be mature ...